Details for Patent: 7,807,689
✉ Email this page to a colleague
Which drugs does patent 7,807,689 protect, and when does it expire?
Patent 7,807,689 protects KAZANO, NESINA, and OSENI, and is included in three NDAs.
This patent has fifty-eight patent family members in thirty-five countries.
Summary for Patent: 7,807,689
| Title: | Dipeptidyl peptidase inhibitors |
| Abstract: | The present invention provides a compound of the formula: ##STR00001## or stereoisomers or pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, articles of manufacture comprising the same, and methods of using the same. |
| Inventor(s): | Zhang; Zhiyuan (San Diego, CA), Elder; Bruce J. (Wynantskill, NY), Isbester; Paul K. (Castleton, NY), Palmer; Grant J. (Clifton Park, NY), Ulysse; Luckner G. (Albany, NY) |
| Assignee: | Takeda Pharmaceutical Company Limited (Osaka, JP) |
| Application Number: | 11/080,992 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,807,689 |
|
Patent Claim Types: see list of patent claims | Compound; Composition; Formulation; Dosage form; Delivery; Use; |
Drugs Protected by US Patent 7,807,689
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Takeda Pharms Usa | KAZANO | alogliptin benzoate; metformin hydrochloride | TABLET;ORAL | 203414-002 | Jan 25, 2013 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | METHOD OF TREATING DIABETES COMPRISING ADMINISTERING ALOGLIPTIN | ⤷ Try a Trial | ||
| Takeda Pharms Usa | KAZANO | alogliptin benzoate; metformin hydrochloride | TABLET;ORAL | 203414-001 | Jan 25, 2013 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | METHOD OF TREATING DIABETES COMPRISING ADMINISTERING ALOGLIPTIN | ⤷ Try a Trial | ||
| Takeda Pharms Usa | NESINA | alogliptin benzoate | TABLET;ORAL | 022271-001 | Jan 25, 2013 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | METHOD OF TREATING DIABETES COMPRISING ADMINISTERING ALOGLIPTIN | ⤷ Try a Trial | ||
| Takeda Pharms Usa | NESINA | alogliptin benzoate | TABLET;ORAL | 022271-002 | Jan 25, 2013 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | METHOD OF TREATING DIABETES COMPRISING ADMINISTERING ALOGLIPTIN | ⤷ Try a Trial | ||
| Takeda Pharms Usa | NESINA | alogliptin benzoate | TABLET;ORAL | 022271-003 | Jan 25, 2013 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | METHOD OF TREATING DIABETES COMPRISING ADMINISTERING ALOGLIPTIN | ⤷ Try a Trial | ||
| Takeda Pharms Usa | OSENI | alogliptin benzoate; pioglitazone hydrochloride | TABLET;ORAL | 022426-004 | Jan 25, 2013 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | METHOD OF TREATING DIABETES COMPRISING ADMINISTERING ALOGLIPTIN | ⤷ Try a Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,807,689
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 048055 | ⤷ Try a Trial | |||
| Argentina | 103423 | ⤷ Try a Trial | |||
| Austria | E401320 | ⤷ Try a Trial | |||
| Australia | 2004318013 | ⤷ Try a Trial | |||
| Brazil | PI0418639 | ⤷ Try a Trial | |||
| Canada | 2559302 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
